Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe
Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 在附件 II 中被列为在欧盟市场上市的化妆品的禁用物质。
记录详情
化学名称
Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe
监管信息
关键数据
化学身份与性质

Amphetamine
1-phenylpropan-2-amine is a primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group. — ChEBI
- IUPAC 名称
- 1-phenylpropan-2-amine
- 分子式
- C9H13N
- 分子量
- 135.21 g/mol
- 精确质量
- 135.104799419 Da
- XLogP3
- 1.8
- 拓扑极性表面积
- 26.0 Ų
- 氢键供体
- 1
- 氢键受体
- 1
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 的清单链接
Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 的相关记录
该记录的直接匹配结果有限,因此同时显示附件 II 中的相邻条目。
Aniline, its salts and its halogenated and sulphonated derivatives
附件 II 对 Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 意味着什么
Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 被列为欧盟化妆品法规 1223/2009 附件 II 中的禁用物质,不得有意添加。第 17 条另行规定了在良好生产规范下技术上不可避免、且符合第 3 条安全要求的非有意微量存在的情形。
配方师必须筛查其成分和原料,确保均不含该物质。供应商应在被要求时提供证明不含该物质的文件。
本记录与 11 个 CosIng 清单成分相关联,便于名称和标识符的交叉引用。 本页还显示 12 条相关附件记录,其标识符、附件逻辑或命名模式存在重叠。
合规核查清单
- 核实该物质不存在于所有原料和成品配方中。
- 向原料供应商索取不含该物质的确认函或 CoA。
- 将筛查结果记录在产品信息档案 (PIF) 中。
常见问题
附件 II 记录 Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 的来源说明
本页概述欧盟委员会公开化妆品资料中 Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 的一条附件 II 记录,并在可用时补充关联的清单或标识符匹配。
请使用本记录页面查看 Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 的附件 II 条件,但任何最终监管决定都应对照现行官方附件措辞和来源文件确认。
工具与后续步骤
检查您的配方
粘贴完整的 INCI 成分表,一次性检出 Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 及其他被标记的欧盟附件记录。
INCI 检查器条目对比
将 Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of Europe 与另一条附件记录并排对比,查看限制、浓度和附件归属的差异。
对比